Ph.D. in Materials Physics and Chemistry with a specialization in Nanotechnology. Expertise in molecular imaging and ultra-small Cornell Prime Dot (C'Dot) technologies developed through post-doctoral training at the University of Wisconsin-Madison and translational research work at Memorial Sloan Kettering Cancer Center. Led Formulation/Platform development at Elucida Oncology (a clinical-stage biotechnology company) and was a key contributor to the FDA IND clearance of ELU001 (anti-human folate receptor alpha Nanoparticle-Drug Conjugates, NDC). Advanced the C’Dot diagnostic and therapeutic technologies and co-invented 6 patents. Now serve as an Instructor of Materials Physics at Weill Cornell Medicine's Molecular Imaging Innovations Institute. Google Scholar Publication Link.